Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Dopamine D1 | 17 | 2019 | 89 | 4.420 |
Why?
|
| Oxidative Stress | 25 | 2023 | 1149 | 4.310 |
Why?
|
| Kidney Tubules, Proximal | 14 | 2020 | 121 | 3.030 |
Why?
|
| Kidney | 20 | 2023 | 2121 | 2.950 |
Why?
|
| Hypertension | 14 | 2020 | 1596 | 2.630 |
Why?
|
| Antioxidants | 14 | 2023 | 522 | 2.550 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 14 | 2019 | 134 | 2.130 |
Why?
|
| NF-E2-Related Factor 2 | 5 | 2022 | 256 | 1.890 |
Why?
|
| Angiotensin I | 3 | 2023 | 16 | 1.790 |
Why?
|
| Receptor, Angiotensin, Type 1 | 6 | 2014 | 78 | 1.740 |
Why?
|
| Natriuresis | 6 | 2019 | 38 | 1.540 |
Why?
|
| Buthionine Sulfoximine | 9 | 2020 | 42 | 1.480 |
Why?
|
| Blood Pressure | 10 | 2020 | 1575 | 1.260 |
Why?
|
| Protein Kinase C | 7 | 2016 | 411 | 1.220 |
Why?
|
| Rats | 28 | 2022 | 6522 | 1.200 |
Why?
|
| Peptide Fragments | 3 | 2023 | 1309 | 1.190 |
Why?
|
| Dopamine | 6 | 2019 | 333 | 1.190 |
Why?
|
| Sodium-Hydrogen Exchangers | 6 | 2019 | 78 | 1.150 |
Why?
|
| Angiotensin II | 4 | 2023 | 198 | 1.130 |
Why?
|
| Insulin | 8 | 2016 | 1487 | 1.130 |
Why?
|
| Sodium Chloride, Dietary | 3 | 2019 | 39 | 1.050 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2019 | 2211 | 1.020 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 10 | 2019 | 39 | 0.910 |
Why?
|
| Nitric Oxide | 5 | 2018 | 657 | 0.890 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 3 | 2019 | 23 | 0.870 |
Why?
|
| Cyclic N-Oxides | 7 | 2020 | 97 | 0.870 |
Why?
|
| Hypertension, Renal | 2 | 2015 | 37 | 0.820 |
Why?
|
| Reperfusion Injury | 2 | 2022 | 151 | 0.810 |
Why?
|
| Mitochondrial Diseases | 1 | 2023 | 145 | 0.800 |
Why?
|
| Dopamine Agonists | 9 | 2019 | 88 | 0.780 |
Why?
|
| Reactive Oxygen Species | 3 | 2023 | 1006 | 0.780 |
Why?
|
| Diuresis | 4 | 2019 | 63 | 0.760 |
Why?
|
| Sodium | 4 | 2019 | 338 | 0.740 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2020 | 39 | 0.720 |
Why?
|
| beta-Adrenergic Receptor Kinases | 4 | 2007 | 57 | 0.710 |
Why?
|
| Spin Labels | 7 | 2020 | 69 | 0.700 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2020 | 118 | 0.690 |
Why?
|
| Nephritis | 1 | 2019 | 41 | 0.680 |
Why?
|
| Hyperinsulinism | 4 | 2010 | 86 | 0.660 |
Why?
|
| Hypoglycemic Agents | 4 | 2016 | 600 | 0.630 |
Why?
|
| Up-Regulation | 4 | 2014 | 2421 | 0.630 |
Why?
|
| Mesenteric Arteries | 1 | 2018 | 64 | 0.600 |
Why?
|
| Oxidants | 4 | 2014 | 50 | 0.590 |
Why?
|
| Mitochondria | 2 | 2020 | 1300 | 0.540 |
Why?
|
| Animals | 35 | 2022 | 62021 | 0.540 |
Why?
|
| Signal Transduction | 10 | 2020 | 12104 | 0.530 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2016 | 1710 | 0.520 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 485 | 0.520 |
Why?
|
| NF-kappa B | 3 | 2014 | 1562 | 0.510 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 573 | 0.490 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 495 | 0.490 |
Why?
|
| Stilbenes | 2 | 2015 | 86 | 0.480 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 758 | 0.470 |
Why?
|
| Type C Phospholipases | 3 | 2011 | 62 | 0.460 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2014 | 328 | 0.460 |
Why?
|
| Gastrins | 1 | 2013 | 50 | 0.450 |
Why?
|
| Epithelial Cells | 2 | 2020 | 1872 | 0.440 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2011 | 277 | 0.430 |
Why?
|
| Phosphoproteins | 1 | 2018 | 1137 | 0.410 |
Why?
|
| Vasodilation | 2 | 2018 | 216 | 0.400 |
Why?
|
| Microvilli | 3 | 2008 | 87 | 0.390 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 4 | 2013 | 13 | 0.390 |
Why?
|
| Carbohydrate Metabolism | 2 | 2008 | 70 | 0.370 |
Why?
|
| Rats, Zucker | 6 | 2010 | 60 | 0.370 |
Why?
|
| Obesity | 5 | 2007 | 2911 | 0.370 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2008 | 668 | 0.360 |
Why?
|
| GTP-Binding Proteins | 3 | 2007 | 342 | 0.350 |
Why?
|
| Serine | 4 | 2018 | 392 | 0.350 |
Why?
|
| Phosphorylation | 7 | 2018 | 4947 | 0.350 |
Why?
|
| Apoptosis | 2 | 2023 | 7753 | 0.340 |
Why?
|
| Physical Conditioning, Animal | 1 | 2010 | 115 | 0.330 |
Why?
|
| MicroRNAs | 1 | 2022 | 2890 | 0.320 |
Why?
|
| Receptors, Dopamine | 1 | 2008 | 52 | 0.310 |
Why?
|
| Uranyl Nitrate | 1 | 2008 | 3 | 0.310 |
Why?
|
| Vasoconstrictor Agents | 1 | 2008 | 166 | 0.300 |
Why?
|
| Sodium Chloride | 1 | 2007 | 159 | 0.290 |
Why?
|
| Gentamicins | 1 | 2007 | 112 | 0.290 |
Why?
|
| Dopamine Antagonists | 3 | 2019 | 61 | 0.290 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2007 | 51 | 0.290 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2006 | 46 | 0.280 |
Why?
|
| Opossums | 3 | 2016 | 17 | 0.280 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 3341 | 0.280 |
Why?
|
| RNA, Messenger | 2 | 2015 | 6394 | 0.270 |
Why?
|
| Hydrogen Peroxide | 2 | 2023 | 223 | 0.270 |
Why?
|
| Male | 25 | 2022 | 128105 | 0.270 |
Why?
|
| Cell Line | 4 | 2020 | 5339 | 0.250 |
Why?
|
| Malondialdehyde | 4 | 2011 | 50 | 0.250 |
Why?
|
| Enzyme Activation | 4 | 2011 | 1814 | 0.250 |
Why?
|
| Rats, Inbred SHR | 3 | 2015 | 112 | 0.240 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 5 | 2007 | 43 | 0.230 |
Why?
|
| Benzazepines | 3 | 2019 | 116 | 0.220 |
Why?
|
| Enzyme Inhibitors | 4 | 2020 | 1946 | 0.210 |
Why?
|
| Endothelial Cells | 1 | 2007 | 1038 | 0.180 |
Why?
|
| Ischemia | 2 | 2022 | 402 | 0.170 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 4136 | 0.170 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2020 | 317 | 0.170 |
Why?
|
| Eating | 3 | 2015 | 446 | 0.170 |
Why?
|
| Disease Models, Animal | 5 | 2015 | 7371 | 0.160 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 3 | 2007 | 80 | 0.160 |
Why?
|
| Inflammation | 2 | 2020 | 2512 | 0.150 |
Why?
|
| TRPC Cation Channels | 1 | 2018 | 25 | 0.150 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 705 | 0.150 |
Why?
|
| Cell Membrane | 3 | 2007 | 882 | 0.150 |
Why?
|
| Blood Glucose | 4 | 2006 | 1270 | 0.150 |
Why?
|
| Adenylyl Cyclases | 2 | 2007 | 103 | 0.150 |
Why?
|
| Thioctic Acid | 2 | 2007 | 13 | 0.140 |
Why?
|
| Lysosomes | 1 | 2019 | 345 | 0.140 |
Why?
|
| Rats, Inbred WKY | 2 | 2015 | 110 | 0.140 |
Why?
|
| Body Weight | 3 | 2015 | 1310 | 0.140 |
Why?
|
| Alkaline Phosphatase | 2 | 2007 | 213 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 1565 | 0.140 |
Why?
|
| Aorta | 2 | 2014 | 671 | 0.140 |
Why?
|
| Protein Transport | 2 | 2010 | 738 | 0.140 |
Why?
|
| RNA Interference | 1 | 2020 | 1386 | 0.130 |
Why?
|
| Drinking | 2 | 2015 | 52 | 0.130 |
Why?
|
| Proline | 2 | 2014 | 127 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2020 | 997 | 0.120 |
Why?
|
| Thiocarbamates | 1 | 2014 | 18 | 0.120 |
Why?
|
| Thiocyanates | 1 | 2013 | 18 | 0.110 |
Why?
|
| Sulfoxides | 1 | 2013 | 22 | 0.110 |
Why?
|
| Vasoconstriction | 1 | 2014 | 119 | 0.110 |
Why?
|
| Isothiocyanates | 1 | 2013 | 44 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 1516 | 0.100 |
Why?
|
| Calcium | 1 | 2018 | 1593 | 0.100 |
Why?
|
| Radioimmunoassay | 1 | 2011 | 203 | 0.090 |
Why?
|
| Kidney Cortex | 2 | 2008 | 31 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2014 | 5690 | 0.090 |
Why?
|
| Albuminuria | 1 | 2010 | 111 | 0.090 |
Why?
|
| Tyrosine | 1 | 2011 | 509 | 0.080 |
Why?
|
| Organ Size | 1 | 2011 | 692 | 0.080 |
Why?
|
| Amidohydrolases | 1 | 2009 | 24 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 7093 | 0.080 |
Why?
|
| Rats, Wistar | 2 | 2007 | 598 | 0.080 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2008 | 15 | 0.080 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2008 | 27 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 3471 | 0.080 |
Why?
|
| Cyclic GMP | 1 | 2008 | 121 | 0.080 |
Why?
|
| Glycosuria | 1 | 2008 | 7 | 0.080 |
Why?
|
| Tetrazoles | 1 | 2008 | 95 | 0.080 |
Why?
|
| Membranes | 1 | 2007 | 32 | 0.080 |
Why?
|
| Urodynamics | 1 | 2008 | 54 | 0.080 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2007 | 55 | 0.080 |
Why?
|
| Electrolytes | 1 | 2008 | 64 | 0.080 |
Why?
|
| Glutathione Peroxidase | 1 | 2007 | 64 | 0.070 |
Why?
|
| Catalase | 1 | 2007 | 75 | 0.070 |
Why?
|
| Enzymes | 1 | 2008 | 71 | 0.070 |
Why?
|
| Injections, Intraperitoneal | 1 | 2007 | 209 | 0.070 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2007 | 19 | 0.070 |
Why?
|
| Biphenyl Compounds | 1 | 2008 | 188 | 0.070 |
Why?
|
| Lipid Peroxidation | 1 | 2007 | 162 | 0.070 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 156 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 878 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 269 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2011 | 2321 | 0.070 |
Why?
|
| Potassium | 1 | 2007 | 346 | 0.070 |
Why?
|
| Janus Kinase 2 | 1 | 2011 | 754 | 0.070 |
Why?
|
| Cyclic AMP | 1 | 2006 | 383 | 0.070 |
Why?
|
| Arginine | 1 | 2009 | 508 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2008 | 433 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 592 | 0.060 |
Why?
|
| Benzimidazoles | 1 | 2008 | 437 | 0.060 |
Why?
|
| Phosphates | 1 | 2005 | 178 | 0.060 |
Why?
|
| Heart | 1 | 2011 | 1195 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2007 | 3592 | 0.060 |
Why?
|
| Humans | 5 | 2023 | 270457 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 884 | 0.060 |
Why?
|
| Ligands | 1 | 2005 | 1016 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2007 | 694 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2003 | 218 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2002 | 147 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 1582 | 0.040 |
Why?
|
| Mice | 1 | 2020 | 35592 | 0.040 |
Why?
|
| Diet | 1 | 2007 | 1481 | 0.040 |
Why?
|
| Thiazoles | 1 | 2002 | 723 | 0.040 |
Why?
|
| Models, Biological | 1 | 2007 | 3196 | 0.040 |
Why?
|
| Gene Expression | 1 | 2005 | 3638 | 0.030 |
Why?
|
| Time Factors | 2 | 2007 | 12991 | 0.030 |
Why?
|
| Biomarkers | 1 | 2007 | 5054 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 3164 | 0.030 |
Why?
|
| Reperfusion | 1 | 2005 | 25 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2005 | 84 | 0.020 |
Why?
|
| Phorbol Esters | 1 | 2005 | 42 | 0.020 |
Why?
|
| Phosphorus | 1 | 2005 | 69 | 0.020 |
Why?
|
| Thyroid Hormones | 1 | 2005 | 112 | 0.020 |
Why?
|
| Biological Transport | 1 | 2005 | 632 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2005 | 309 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2002 | 329 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 2220 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2002 | 2091 | 0.010 |
Why?
|
| Glucose | 1 | 2002 | 1222 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 5071 | 0.010 |
Why?
|